Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.

S. Ferrini, A. Cambiaggi, S. Sforzini, S. Canevari, D. Mezzanzanica, M. I. Colnaghi, L. Moretta

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.'. Together they form a unique fingerprint.

Medicine & Life Sciences